<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03623412</url>
  </required_header>
  <id_info>
    <org_study_id>0068-18</org_study_id>
    <nct_id>NCT03623412</nct_id>
  </id_info>
  <brief_title>Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose Tolerance Test</brief_title>
  <official_title>Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clalit Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clalit Health Services</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to offer a 75g postpartum glucose tolerance test to women with minor
      degrees of glucose intolerance and to assess if these women are significantly different from
      women who were diagnosed as GDM (Gestational Diabetes Mellitus)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive post-partum GTT results</measure>
    <time_frame>6-12 weeks post partum</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Glucose Tolerance Impaired in Pregnancy</condition>
  <arm_group>
    <arm_group_label>One abnormal value</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with only one abnormal value on OGTT (Oral Glucose Tolerance Test) during pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GDM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women with two abnormal values on OGTT during pregnancy - diagnosis=GDM</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>75g oral glucose tolerance test</intervention_name>
    <description>Women with one abnormal value in the OGTT during pregnancy (minor degree of glucose intolerance) will be offered a post-partum 75g GTT (Glucose Tolerance Test), similar to that offered to women with GDM</description>
    <arm_group_label>One abnormal value</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>75g GTT</intervention_name>
    <description>post-partum GTT</description>
    <arm_group_label>GDM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy women (without pre-existing diabetes) who underwent an OGTT during pregnancy

        Exclusion Criteria:

          -  pre-existing diabetes, or failed to perform the OGTT
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 6, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>August 12, 2018</last_update_submitted>
  <last_update_submitted_qc>August 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

